Search
Sight Sciences Inc
SGHTAdd to Watchlist
5.450USD
+0.010+0.18%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
291.54MMarket Cap
LossP/E TTM
More Details of Sight Sciences Inc Company
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Sight Sciences Inc Info
Ticker SymbolSGHT
Company nameSight Sciences Inc
IPO dateJul 15, 2021
CEOBadawi (Paul)
Number of employees216
Security typeOrdinary Share
Fiscal year-endJul 15
Address4040 Campbell Ave,
CityMENLO PARK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94025
Phone14158890550
Websitehttps://www.sightsciences.com/
Ticker SymbolSGHT
IPO dateJul 15, 2021
CEOBadawi (Paul)
Company Executives of Sight Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.54M
+3.64%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
2.07M
+2.05%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.80M
+2.22%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Operating Officer, Principal Operating Officer
Chief Operating Officer, Principal Operating Officer
169.81K
-7.50%
Mr. Donald J. Zurbay, CPA
Mr. Donald J. Zurbay, CPA
Independent Director
Independent Director
103.61K
+27.28%
Ms. Catherine Mazzacco
Ms. Catherine Mazzacco
Independent Director
Independent Director
96.70K
+29.22%
Mr. Jeremy Bragg Hayden, J.D.
Mr. Jeremy Bragg Hayden, J.D.
Chief Legal Officer
Chief Legal Officer
87.27K
-40.39%
Mr. Gerhard F. (Gary) Burbach
Mr. Gerhard F. (Gary) Burbach
Independent Director
Independent Director
73.18K
+38.62%
Dr. Tamara R. Fountain, M.D.
Dr. Tamara R. Fountain, M.D.
Independent Director
Independent Director
--
--
Mr. Jim Rodberg
Mr. Jim Rodberg
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.54M
+3.64%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
2.07M
+2.05%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.80M
+2.22%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Operating Officer, Principal Operating Officer
Chief Operating Officer, Principal Operating Officer
169.81K
-7.50%
Mr. Donald J. Zurbay, CPA
Mr. Donald J. Zurbay, CPA
Independent Director
Independent Director
103.61K
+27.28%
Ms. Catherine Mazzacco
Ms. Catherine Mazzacco
Independent Director
Independent Director
96.70K
+29.22%
FAQs
Who are the top five shareholders of Sight Sciences Inc?
The top five shareholders of Sight Sciences Inc are: Mr. Paul Badawi
How many institutions hold shares of Sight Sciences Inc (SGHT)?
As of 2026Q1, 200 institutions hold shares of Sight Sciences Inc, with a combined market value of approximately 27.85M, accounting for 51.74% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 944720.00.